LEADER 01889oam  2200553   450 
001 9910709757803321
005 20181109142344.0
035   $a(CKB)5470000002472668
035   $a(OCoLC)1042074892
035   $a(EXLCZ)995470000002472668
100   $a20180627d2018      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicaid Pharmaceutical Home Act of 2018 $ereport together with additional views (to accompany H.R. 5808) (including cost estimate of the Congressional Budget Office)
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2018]
215   $a1 online resource (36 pages)
225 1 $aReport / 115th Congress, 2d session, House of Representatives ;$v115-726
300   $a"June 12, 2018."
320   $aIncludes bibliographical references.
517   $aMedicaid Pharmaceutical Home Act of 2018 
606   $aMedicaid
606   $aMedicare
606   $aDrugs$xPrescribing$zUnited States$xManagement
606   $aOpioid abuse$xTreatment$zUnited States$xCosts
606   $aDrug development$xGovernment policy$zUnited States
606   $aDrugs$xGeneric substitution$xGovernment policy$zUnited States
608   $aLegislative materials.$2lcgft
615  0$aMedicaid.
615  0$aMedicare.
615  0$aDrugs$xPrescribing$xManagement.
615  0$aOpioid abuse$xTreatment$xCosts.
615  0$aDrug development$xGovernment policy
615  0$aDrugs$xGeneric substitution$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bIUL
801  2$bMERUC
801  2$bOCLCF
801  2$bIUL
801  2$bINT
801  2$bGPO
906   $aBOOK
912   $a9910709757803321
996   $aMedicaid Pharmaceutical Home Act of 2018$93500337
997   $aUNINA